ERX is not a joke company and should not be seen as a fast buck, ERX is a serous drug company developing some very important therapies for cancer that could one day save the life of any one of our families including ourself's, that's that bit out of the way.
They have collaborations and Intellectual Property agreement with Almac Diagnostics, bioMerieux SA, future milestones and royalties that could run into millions on the successful development of ZYC300. A similar success-based milestone arrangement pertains to the Company's licensing of drug targets to OSI Pharmaceuticals also payments could come from bioMerieux and MGI Pharma Just one small payment from any one of these companies will see the sp surge. The M/Cap is ridiculously small for such a bio company with so much going on IMO erx will have a successful placing next year, a development break through or some milestones payments in 2007 Not a share to be out of Top Up on the dips.